Oral lysozyme can prevent the excessive growth of E. coli and visceral hypersensitivity induced by maternal isolation, thus achieving the prevention and treatment of NEC (Riba et al., 2017). This evidence concerns the gene LYZ and necrotizing enterocolitis.